Original Article

Efficacy of Propolis in Diabetic Foot Ulcer Management (or Treatment): A Randomized Controlled Trial

Abstract

Background: The impaired wound healing in diabetes mellitus is a major clinical problem. Propolis has pharmacological characteristics. This study aimed to evaluate the effects of oral, topical, and oral combined with topical administration of propolis on foot ulcers in diabetic patients.
Methods: Eighty patients with diabetic foot ulcers were divided into 4 groups. Group 1 received propolis ointment (3%, 1.5 g daily), Group 2 received three 500-mg propolis capsules per day, Group 3 received capsules and ointments, and Group 4 received the usual treatment of foot ulcer, including washing with physiological serum. The patients were treated for 4 weeks. Wound surface area changes were analyzed to determine the effectiveness of the compound in wound healing.
Results: The interventions decreased foot ulcer surface areas in all intervention groups (from 685.13 ± 286.16 to 74.89 ± 26.40 mm2 [p = 0.03] in Group 1, from 616.52 ± 221.11 to 104.60 ± 39.81 mm2 [p = 0.046] in Group 2, and from 647.07 ± 23 to 54.20 ± 19.17 mm2 [p = 0.01] in Group 3). In Group 4, however, the reduction in ulcer surface area was not statistically significant. In the three experimental groups, the wounds were clinically improved in all subjects.
Conclusion: This study showed that in diabetic foot ulcers, treatment with either oral propolis capsules or combination therapy with oral and topical forms, significantly improves wound healing. Also, the application of these products does not seem to be associated with any unexpected adverse event.

1. Kiani J, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Archives of Iranian medicine. 2013;16(1):17.
2. Kiadaliri AA, Najafi B, Mirmalek-Sani M. Quality of life in people with diabetes: a systematic review of studies in Iran. Journal of Diabetes & Metabolic Disorders. 2013;12(1):54.
3. Al-Geffari M. Comparison of different screening tests for diagnosis of diabetic peripheral neuropathy in Primary Health Care setting. International journal of health sciences. 2012;6(2):127.
4. Bagheri M, Fayazi S, Rabee Z, Aarabi M, Latifi SM, Basiri G, et al. Barriers in controlling blood glucose in type 2 diabetes patients with diabetic foot ulcer, Ahvaz Razi Hospital, 2012. J Chronic Dis Care. 2012;2(2):17-25.
5. Sharifmoradi K, Karimi MT, Rezaeeyan Z. The Effects of Negative Heel Rocker Shoes on the Moment and the Contact Forces Applied on Lower Limb Joints of Diabetic Patients During Walking. Physical Treatments-Specific Physical Therapy Journal. 2016;6(3):129-36.
6. Chuan F, Tang K, Jiang P, Zhou B, He X. Reliability and validity of the perfusion, extent, depth, infection and sensation (PEDIS) classification system and score in patients with diabetic foot ulcer. PloS one. 2015;10(4):e0124739.
7. Fard AS, Esmaelzadeh M, Larijani B. Assessment and treatment of diabetic foot ulcer. International journal of clinical practice. 2007;61(11):1931-8.
8. Wieman TJ, Smiell JM, Su Y. Efficacy and safely of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes care. 1998;21(5):822-7.
9. Lotfy M. Biological activity of bee propolis in health and disease. Asian Pac J Cancer Prev. 2006;7(1):22-31.
10. Afsharpour F, Hashemipour S, Khadem-Haghighian H, Koushan Y. Effects of Iranian propolis on glucose metabolic changes, inflammatory factors, liver enzymes levels in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Journal of Nutritional Sciences and Dietetics. 2017;3(2).
11. Fernandes Jr A, Balestrin E, Cunha M. Anti Staphylococcus aureus activity of bee propolis extracts prepared with different ethanol concentrations. Revista de Ciências Farmacêuticas. 2003;24(2):147-52.
12. Khadem HH, Koushan Y, Asgharzadeh A. Treatment of Diabetic Foot Ulcer with Propolis and Olive Oil: A Case Report. 2012.
13. Ghosh S, Saha S, Hossain S, Sengupta D, Roy S, Roy C. Healing of Diabetic Foot Ulcer by Homeopathic Therapeutic Aid: A Case Study. American Journal of Homeopathic Medicine. 2012;105(1).
14. Farooqui T, Farooqui AA. Beneficial effects of propolis on human health and neurological diseases. Front Biosci (Elite Ed). 2012;4:779-93.
15. Guo X, Chen B, Luo L, Zhang X, Dai X, Gong S. Chemical compositions and antioxidant activities of water extracts of Chinese propolis. Journal of agricultural and food chemistry. 2011;59(23):12610-6.
16. Abreu AM, Oliveira DWD, Marinho SA, Lima NL, de Miranda JL, Verli FD. Effect of topical application of different substances on fibroplasia in cutaneous surgical wounds. ISRN dermatology. 2012;2012.
17. Panzarini SR, Nonato CC, Gulinelli JL, Poi WR, Sonoda CK, Saito CTMH, et al. Effect of the treatment of root surface-adhered necrotic periodontal ligament with propolis or fluoride in delayed rat tooth replantation. Clinical oral investigations. 2014;18(4):1329-33.
18. Temiz M, Aslan A, Canbolant E, Hakverdi S, Polat G, Uzun S, et al. Effect of propolis on healing in experimental colon anastomosis in rats. Advances in therapy. 2008;25(2):159-67.
19. Sehn E, Hernandes L, Franco S, Gonçalves C, Baesso M. Dynamics of reepithelialisation and penetration rate of a bee propolis formulation during cutaneous wounds healing. Analytica Chimica Acta. 2009;635(1):115-20.
20. Gulinelli JL, Panzarini SR, Fattah CMRdS, Poi WR, Sonoda CK, Negri MR, et al. Effect of root surface treatment with propolis and fluoride in delayed tooth replantation in rats. Dental Traumatology. 2008;24(6):651-7.
21. Paulino N, Abreu SRL, Uto Y, Koyama D, Nagasawa H, Hori H, et al. Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. European Journal of Pharmacology. 2008;587(1):296-301.
22. Serarslan G, Altuğ E, Kontas T, Atik E, Avci G. Caffeic acid phenetyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress. Clinical and experimental dermatology. 2007;32(6):709-15.
23. McLennan SV, Bonner J, Milne S, Lo L, Charlton A, Kurup S, et al. The anti‐inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair and Regeneration. 2008;16(5):706-13.
24. Ahmed N. Advanced glycation endproducts—role in pathology of diabetic complications. Diabetes research and clinical practice. 2005;67(1):3-21.
25. Bankova V. Chemical diversity of propolis and the problem of standardization. Journal of ethnopharmacology. 2005;100(1):114-7.
26. Russo A, Longo R, Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia. 2002;73:S21-S9.
27. Hussain Z, Thu HE, Shuid AN, Katas H, Hussain F. Recent advances in polymer-based wound dressings for the treatment of diabetic foot ulcer: an overview of state-of-the-art. Current Drug Targets. 2017;18:000-.
28. Leaper D, Meaume S, Apelqvist J. Debridement methods of non-viable tissue in wounds. Cambridge: Woodhead Publishing; 2011.
Files
IssueVol 3, No 4 (Autumn 2017) QRcode
SectionOriginal Article(s)
Published2017-10-06
Keywords
Diabetes mellitus Diabetic ulcers Propolis Wound healing

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Shekari M, Koushan Y, Kachooie A, Khadem Haghighian H. Efficacy of Propolis in Diabetic Foot Ulcer Management (or Treatment): A Randomized Controlled Trial. J Nutr Sci & Diet. 3(4):9-13.